Abstract
Lung stereotactic body radiation therapy (SBRT) is a novel and effective modality for treatment of early stage non-sail cell lung cancer (NSCLC), with expanding indications in locally advanced and metastatic disease. Herein, we will review current treatment recommendations for early stage NSCLC, detail treatment planning of SBRT, and discuss future directions.
Original language | English |
---|---|
Pages (from-to) | 361-365 |
Number of pages | 5 |
Journal | Missouri Medicine |
Volume | 112 |
Issue number | 5 |
State | Published - Sep 1 2015 |